OB/GYN Clinical Alert
RSSArticles
-
Pharmacology Watch: Rivaroxaban Now Approved for Stroke Prevention
In this issue: New indication for rivaroxaban; new study on warfarin testing; medications causing adverse drug events; niacin as an add-on therapy; and FDA actions. -
Do We Have a New Standard of Care for Advanced Ovarian Cancer?
Vascular endothelial growth factor (vegf) is a key factor in the normal and tumor microenvironment regulating angiogenesis. -
Pharmacology Watch: New, Shorter Treatment Regimen for Tuberculosis
In this issue: New treatment for TB; safety of dabigatran; quality of antidepressants; systolic hypertension treatment; and FDA actions. -
Clinical Briefs in Primary Care supplement
-
Do Combined Oral Contraceptives Worsen Breastfeeding Outcomes?
The authors performed a randomized, double-blind study to compare the effects of progestin-only and combined hormonal contraceptive pills on rates of breastfeeding continuation in postpartum women. -
Hyperemesis Gravidarum and Adverse Perinatal Outcomes
How often are we asked whether a patient who has had severe nausea and vomiting in early pregnancy has a greater chance of adverse outcome in her pregnancy? -
Is There an Increased Risk of HIV Transmission with Use of Hormonal Contraception?
Heffron et al conducted a secondary analysis of two longitudinal studies (2004-2010) performed in Africa. -
Clinical Briefs in Primary Care Supplement
-
Findings in Female Offspring of Women Exposed In Utero to Diethylstilbestrol
-
Clinical Briefs in Primary Care Supplement